Moderna Says Its COVID-19 Vaccine Effective, Safe in Children Ages 6 to 11

Vials of Moderna's COVID-19 vaccine are seen in Bridgeport, Conn., in a file photograph. Joseph Prezioso/AFP via Getty Images

Moderna said Monday that its COVID-19 vaccine is able to generate a strong immune response in children ages 6 to 11, citing a new study.

The company said that an interim analysis of data showed a “robust neutralizing antibody response” after two shots of its mRNA-1273 vaccine were administered at a 50 microgram dose level, or half the dosage of the vaccine used in adults, to children in this age group.